HARRISBURG, Pa. -- The nation's largest pharmacy benefits manager said Monday it has agreed to pay $29 million to settle allegations by 20 states that it was switching patients to medications to save itself money, not to benefit the patients.
Medco Health Solutions Inc. will also be required to make a number of disclosures to prescribers and patients. Those include the minimum or actual cost savings for health plans and the difference in a patient's co-payment, the difference in side effects between prescribed and proposed medications, and Medco's financial incentives for certain drug switches.
The agreement does not include an admission or finding of inappropriate business conduct by the Franklin Lakes, N.J.-based company.
Medco, like other pharmacy benefits managers, contracts with health plans to process prescription drug payments to pharmacies for medications provided to patients enrolled in the health plans.
The settlement was spearheaded by authorities in Pennsylvania, Massachusetts and Maine, and includes Arizona, California, Connecticut, Delaware, Florida, Illinois, Iowa, Louisiana, Maryland, Nevada, New York, North Carolina, Oregon, Texas, Vermont, Virginia and Washington.
"Consumers and their doctors should make the decision of switching from one medication to another based on the best interests of the patient, not because a (pharmacy benefits manager) has found a way to make money," Pennsylvania Attorney General Jerry Pappert said in a statement.
A separate pending federal suit claims Medco ignored safety rules at its mail-order drug centers and pressured doctors to switch patients to medications made by its former owner, pharmaceutical giant Merck & Co.
Medco officials have called those charges either false or overstated.
Copyright 2004, Associated Press. Reprinted with permission.
|